Results 241 to 250 of about 1,739,242 (280)

Comparative effectiveness of apalutamide‐, abiraterone‐, and enzalutamide‐based doublets in mHSPC

open access: yesBJU International, EarlyView.
Background and Objective Treatment of metastatic hormone‐sensitive prostate cancer (mHSPC) has evolved from androgen‐deprivation therapy (ADT) alone to combination therapy with androgen receptor pathway inhibitors. Although apalutamide (APA), abiraterone (ABI), and enzalutamide (ENZA) improve outcomes when added to ADT, direct comparative trials ...
Anikó Katalin Valikovics   +9 more
wiley   +1 more source

Nitric oxide-induced lipophagic defects contribute to testosterone deficiency in rats with spinal cord injury. [PDF]

open access: yesFront Endocrinol (Lausanne)
Zhuang Y   +17 more
europepmc   +1 more source

Suicidal behavior and unsupervised hormone use in outpatient Brazilian transgender adolescents: health and psychosocial factors

open access: yesChild and Adolescent Mental Health, EarlyView.
Background Transgender adolescents are at high risk for negative health outcomes resulting from marginalization and scarcity of services, intensified by the lack of epidemiological data addressing their needs. Understanding the sociodemographic, clinical, and behavioral characteristics of trans youths may support strategies to improve healthcare for ...
Saulo Vito Ciasca   +9 more
wiley   +1 more source

Hormonal Therapy Before Micro‐TESE in Men With Nonobstructive Azoospermia: A Negative Answer to an Overly Broad Question

open access: yes
Andrology, EarlyView.
Sandro C. Esteves   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy